MetaCap

Allogene Therapeutics Statistics

NASDAQ: ALLOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.6277-0.0392 (-5.88%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Allogene Therapeutics by the numbers

Allogene Therapeutics has a market capitalization of $217.5 million based on 346.47M shares outstanding. With trailing EPS of $-0.61, Allogene Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 51.8% below its 50-day average and 67.4% below its 200-day average.

Average daily trading volume is 7.69M shares, or about $4.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ALLO valuation vs. peer median

ALLO compared with the median of 8 peer companies
MetricALLOPeer medianDifference
Market cap$217.48M$220.07M-1%
Avg. volume7.69M1.27M+504%

Peer median across 8 companies: IPSC, SCTX, CABA, LCTX, AUTL, PLX, LXEO, ARTV.

Valuation

Price and trading

Previous close
0.6669
Open
0.642
Day range
0.6192 – 0.67
52-week range
0.6192 – 4.46
52-week change
-48.97%
Beta
—
Volume
7.57M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
217.48M
Forward Pe
-1.06
Eps
-0.61
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
4.46
Week52 Low
0.62
Avg Volume
7.69M
Shares Outstanding
346.47M
Ma50
1.30
Ma200
1.92
Earnings Date
Nov 5, 2026
Pct From52w High
-85.93%
Pct From52w Low
1.37%

Related